INNOVATION PHARMACEUTICALS INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2021-02-22: Study NCT04784897; Company role Lead sponsor; Phase Phase 2; Status Completed.
- 2020-01-06: Study NCT04240223; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2017-02-09: Study NCT03042702; Company role Lead sponsor; Phase Phase 2; Status Completed.
- 2016-11: Study NCT02949388; Company role Lead sponsor; Phase Phase 2; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2021-02-22 | NCT04784897 A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 | Lead sponsor | Phase 2 | Completed Results posted | COVID-19 | 120 | 2021-07-30 |
| 2020-01-06 | NCT04240223 A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers | Lead sponsor | Phase 1 | Completed | Healthy Volunteers | 9 | 2020-02-12 |
| 2017-02-09 | NCT03042702 A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer | Lead sponsor | Phase 2 | Completed Results posted | Ovarian Cancer | 2 | 2017-11-10 |
| 2016-11 | NCT02949388 Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis | Lead sponsor | Phase 2 | Completed | Chronic Stable Plaque Psoriasis | 199 | 2017-12 |
| 2015-08 | NCT02494479 Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis | Lead sponsor | Phase 2 | Completed | Plaque Psoriasis | 115 | 2016-05 |
| 2014-08-14 | NCT02324335 Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer | Lead sponsor | Phase 2 | Completed Results posted | Head and Neck Neoplasms; Mucositis | 61 | 2017-11-22 |
| 2014-03 | NCT02101216 Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers | Lead sponsor | Phase 1 | Completed | Psoriasis | 18 | 2014-10 |
| 2014-02 | NCT02052388 Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections | Lead sponsor | Phase 2 | Completed | Skin Infection; Bacterial Infection | 215 | 2014-10 |
| 2012-10 | NCT01664000 A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors | Lead sponsor | Phase 1 | Completed | Solid Tumors | 48 | 2016-02 |